These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 17601050)
41. Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus. Forrester AJ; Sullivan V; Simmons A; Blacklaws BA; Smith GL; Nash AA; Minson AC J Gen Virol; 1991 Feb; 72 ( Pt 2)():369-75. PubMed ID: 1704412 [TBL] [Abstract][Full Text] [Related]
42. Antibodies to Aujeszky's disease virus in pigs immunized with purified virus glycoproteins. Iglesias G; Molitor T; Reed D; L'Italien J Vet Microbiol; 1990 Jul; 24(1):1-10. PubMed ID: 2171185 [TBL] [Abstract][Full Text] [Related]
43. Glycoprotein gI of pseudorabies virus: epitope-specific antibody response in mice and pigs. Jacobs L; Moonen-Leusen BM; Bianchi AT; Kimman TG Acta Vet Hung; 1994; 42(2-3):347-51. PubMed ID: 7528969 [No Abstract] [Full Text] [Related]
44. Functional aspects of Aujeszky's disease (pseudorabies) viral proteins with relation to invasion, virulence and immunogenicity. Nauwynck HJ Vet Microbiol; 1997 Apr; 55(1-4):3-11. PubMed ID: 9220592 [TBL] [Abstract][Full Text] [Related]
45. Subclinical porcine circovirus type 2 infection does not modulate the immune response to an Aujeszky's disease virus vaccine. Díaz I; Cortey M; Darwich L; Sibila M; Mateu E; Segalés J Vet J; 2012 Oct; 194(1):84-8. PubMed ID: 22464756 [TBL] [Abstract][Full Text] [Related]
46. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. Davies DH; McCausland MM; Valdez C; Huynh D; Hernandez JE; Mu Y; Hirst S; Villarreal L; Felgner PL; Crotty S J Virol; 2005 Sep; 79(18):11724-33. PubMed ID: 16140750 [TBL] [Abstract][Full Text] [Related]
47. Evaluation of tests for detection of antibodies to Aujeszky's disease (pseudorabies) virus glycoprotein E in the target population. Stegeman A; De Jong MC; Van der Heijden HM; Elbers AR; Kimman TG Vet Microbiol; 1997 Apr; 55(1-4):107-11. PubMed ID: 9220602 [TBL] [Abstract][Full Text] [Related]
48. Neutralizing monoclonal antibodies to bovine viral diarrhoea virus bind to the 56K to 58K glycoprotein. Donis RO; Corapi W; Dubovi EJ J Gen Virol; 1988 Jan; 69 ( Pt 1)():77-86. PubMed ID: 2447228 [TBL] [Abstract][Full Text] [Related]
49. Glycosylation of immunodominant linear epitopes in the carboxy-terminal region of the caprine arthritis-encephalitis virus surface envelope enhances vaccine-induced type-specific and cross-reactive neutralizing antibody responses. Trujillo JD; Kumpula-McWhirter NM; Hötzel KJ; Gonzalez M; Cheevers WP J Virol; 2004 Sep; 78(17):9190-202. PubMed ID: 15308714 [TBL] [Abstract][Full Text] [Related]
50. [Direct solid-phase radioimmunoassay for the detection of Aujeszky's disease antibodies (author's transl)]. Döller G; Jakubik J Zentralbl Bakteriol A; 1980 Jun; 247(1):1-7. PubMed ID: 6254286 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1. Mikulska-Skupień E; Szweda W; Procajło Z Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468 [TBL] [Abstract][Full Text] [Related]
52. [A method for distinguishing infected from vaccinated pigs as a basis for the control of Aujeszky's disease]. van Oirschot JT Tijdschr Diergeneeskd; 1988 Jan; 113(1):19-27. PubMed ID: 2829384 [TBL] [Abstract][Full Text] [Related]
53. Constancy of Aujeszky's field virus antibody titres in sows repeatedly vaccinated with a gI-negative vaccine. Hopp W; Jungblut R Acta Vet Hung; 1994; 42(2-3):409-11. PubMed ID: 7810439 [TBL] [Abstract][Full Text] [Related]
54. Mapping and characterization of neutralizing epitopes of glycoproteins gIII and gp50 of the Indiana-Funkhauser strain of pseudorabies virus. Coe NE; Mengeling WL Arch Virol; 1990; 110(1-2):137-42. PubMed ID: 1689995 [TBL] [Abstract][Full Text] [Related]
55. [Development of immunoenzyme methods for detecting antibodies to Aujeszky's disease virus gB glycoprotein in swine serum]. Morenkov OS Vopr Virusol; 2000; 45(3):45-8. PubMed ID: 10867996 [TBL] [Abstract][Full Text] [Related]
56. DNA vaccination induces a long-term antibody response and protective immunity against pseudorabies virus in mice. Ho TY; Hsiang CY; Hsiang CH; Chang TJ Arch Virol; 1998; 143(1):115-25. PubMed ID: 9505970 [TBL] [Abstract][Full Text] [Related]
57. Aujeszky's disease in the guinea pig: cellular and humoral responses following immunization. Ashworth LA; Baskerville A; Lloyd G Arch Virol; 1980; 63(3-4):227-37. PubMed ID: 6243924 [TBL] [Abstract][Full Text] [Related]
58. Antigenic variation of pseudorabies virus glycoproteins g II and g III demonstrated by neutralizing monoclonal antibodies. Yamada S; Imada T; Nishimori T; Sekikawa K; Shimizu M Arch Virol; 1991; 119(3-4):285-90. PubMed ID: 1652239 [TBL] [Abstract][Full Text] [Related]
59. Characterization of protective viral glycoproteins for pseudorabies virus infection. Matsuda A; Okada N; Katayama S; Okabe T; Sasaki N J Vet Med Sci; 1991 Aug; 53(4):737-41. PubMed ID: 1657214 [No Abstract] [Full Text] [Related]
60. Characterization of monoclonal antibodies that recognize the amino- and carboxy-terminal epitopes of the pseudorabies virus UL42 protein. Du W; Wang Y; Huang L; Wei Y; Chen D; Sun J; Wu H; Feng L; Liu C Appl Microbiol Biotechnol; 2016 Jan; 100(1):181-92. PubMed ID: 26377421 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]